about
The economic impact and cost of visual impairment in AustraliaTrachoma and the need for a coordinated community-wide response: a case-based studyDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)Relationship between Community Drug Administration Strategy and Changes in Trachoma Prevalence, 2007 to 2013The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based StudyGlobal Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010.Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy.Methodology and recruitment of probands and their families for the Genes in Myopia (GEM) Study.Further survey of Australian ophthalmologist's diabetic retinopathy management: did practice adhere to National Health and Medical Research Council guidelines?Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data.Diabetic retinopathy in Victoria, Australia: the Visual Impairment ProjectIncreased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.Projected prevalence of age-related cataract and cataract surgery in Australia for the years 2001 and 2021: pooled data from two population-based surveys.Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project.Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment Project.Prevalence and associations of epiretinal membranes in the visual impairment project.Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.Diabetic retinopathy management by Australian optometrists.Compliance with recommendations from a screening programme for diabetic retinopathy.Challenges of ophthalmic care in the developing world.Correlation of clinical trachoma and infection in Aboriginal communitiesEconomic impact of primary open-angle glaucoma in Australia.Dietary carbohydrate in relation to cortical and nuclear lens opacities in the melbourne visual impairment project.Methods for detecting age-related maculopathy: a comparison between photographic and clinical assessment.World blindness: a 21st century perspective.The prevalence of and factors associated with diabetic retinopathy in the Australian population.Vitamin E supplementation and cataract: randomized controlled trial.Access to eye health services among indigenous Australians: an area level analysis.Vision impairment in the Pacific regionLocal co-ordination and case management can enhance Indigenous eye care--a qualitative study.Eye health in rural Australia.Correction of refractive error in the Victorian population: the feasibility of "off the shelf" spectacles.Vision impairment predicts 5 year mortality.Control of trachoma in Australia: a model based evaluation of current interventions.Utilisation of eye care services by urban and rural AustraliansImpact of unilateral and bilateral vision loss on quality of lifeHow to assess the prevalence of trachoma.VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness.
P50
Q24679567-A514D9EC-473B-42D5-BB2B-BE393D4F331AQ25257216-9D36E345-6E5F-41FA-AA8A-7AB2A20941F2Q27860791-55117C7F-35A9-463E-B804-992FFEB3CBBBQ28306815-78AC3C64-D94A-4E87-8F54-0499D7ED9CCEQ28552382-38ACCDAA-7C41-4DD2-8374-8F830DCC27F0Q28603736-FAB087FD-CC04-4985-B731-3EC07715D51DQ30248328-CB35066E-C5D8-46C4-8BAE-4F1751FF597CQ30485861-DE5366A3-D5A7-4735-A5BC-900DDAFF1800Q30691217-B265AB5B-7E2C-4E54-9BF1-6894E11E6617Q30802371-03D6B9D1-5BF0-4E60-BA29-58DDF56CD7A6Q30983258-D4FBD76D-0220-4196-A7DD-1B6E9839ADADQ31141723-9EF01436-74DE-4800-98F8-D16338958339Q31793083-BD1D1B7F-E58A-43DB-967F-ECC9D4A36C0DQ31857855-6E82F5E5-018C-403E-9309-10D6545716A1Q33187275-95CC02C3-0CC9-420E-A4F8-3F72DF4E54A1Q33193480-D8BDC158-1D5F-4E7B-BF58-0F011EC5DFB4Q33195328-139CEE68-FB3E-454C-9D05-88F13733BD59Q33219640-4B7ACC2C-82F1-4FB2-9C96-8C81149AD0B3Q33646509-BC0B4422-5BB5-40EF-8F21-7896C43D0C1BQ33727207-D0DD39B0-2F5A-4733-919E-FEAC391654ACQ33731773-7C59E99C-D8F6-46E5-BC59-BCB2B7C4A71EQ33779376-C127D057-1569-4AF8-BC96-E3E1FED6732AQ33851430-FFE15536-0853-4849-A131-25A5198C1876Q33918990-8398069A-1258-4E9A-BDC1-A7D3BA4DA941Q33938168-A58DEF46-5C3F-4CEE-9E05-8C18805E331AQ34093035-B07D309A-86BB-4A57-B7EE-F79A928CCA48Q34164449-AD0A6CC8-F58E-4E01-8A3D-DD7531F7EEE3Q34199750-656159A6-79D5-42E2-BC7D-5DA78CF5E638Q34288594-D896AA41-59AF-4466-8E23-3BBB7736BE2BQ34418820-531D593F-730E-4898-B3E1-C99C7CC7580CQ34659587-D6B3F510-8181-4303-8AB2-2429B14A0DB2Q34791429-C48B7ABF-3497-44B3-A40C-A654AB2845FEQ34815356-71CBAEE0-A8EC-4A17-90BD-420EB4961982Q35317720-63313D1E-CF22-4748-9CB9-61AFA2F9A2A0Q35318860-7B05970A-CFC4-4EB6-B9AF-F374D0EB6AC6Q35363980-00EAE7C1-09A7-4BDE-B951-F2C67163C293Q35589359-D50063DE-3EB0-40DA-97AB-D11C65718336Q35592985-5B4313B2-9878-4833-BCBF-E2CC14434D2DQ35593114-033F0159-776A-4661-8C70-FB0C8EE15780Q35743924-26EFD7DF-E2EB-461F-B80D-0416E48C52E7
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Hugh R Taylor
@nl
Hugh R Taylor
@sl
Hugh R. Taylor
@en
Hugh R. Taylor
@es
type
label
Hugh R Taylor
@nl
Hugh R Taylor
@sl
Hugh R. Taylor
@en
Hugh R. Taylor
@es
altLabel
Hugh Taylor
@en
prefLabel
Hugh R Taylor
@nl
Hugh R Taylor
@sl
Hugh R. Taylor
@en
Hugh R. Taylor
@es
P1006
P214
P244
P1006
P106
P1153
55550572900
P21
P213
0000 0000 1965 2579
P214
P244
P31
P496
0000-0002-9437-784X
P734
P735
P7859
lccn-n00138560